697 related articles for article (PubMed ID: 20685823)
1. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH.
Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393
[TBL] [Abstract][Full Text] [Related]
3. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
4. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
[TBL] [Abstract][Full Text] [Related]
5. FGF23 and the parathyroid.
Silver J; Naveh-Many T
Adv Exp Med Biol; 2012; 728():92-9. PubMed ID: 22396164
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
9. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.
Meir T; Durlacher K; Pan Z; Amir G; Richards WG; Silver J; Naveh-Many T
Kidney Int; 2014 Dec; 86(6):1106-15. PubMed ID: 24940803
[TBL] [Abstract][Full Text] [Related]
11. Effects of parathyroid hormone on Wnt signaling pathway in bone.
Kulkarni NH; Halladay DL; Miles RR; Gilbert LM; Frolik CA; Galvin RJ; Martin TJ; Gillespie MT; Onyia JE
J Cell Biochem; 2005 Aug; 95(6):1178-90. PubMed ID: 15962290
[TBL] [Abstract][Full Text] [Related]
12. The bone histology spectrum in experimental renal failure: adverse effects of phosphate and parathyroid hormone disturbances.
Batista DG; Neves KR; Graciolli FG; dos Reis LM; Graciolli RG; Dominguez WV; Neves CL; Magalhães AO; Custódio MR; Moysés RM; Jorgetti V
Calcif Tissue Int; 2010 Jul; 87(1):60-7. PubMed ID: 20428857
[TBL] [Abstract][Full Text] [Related]
13. Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects.
Komaba H
Clin Exp Nephrol; 2023 May; 27(5):395-401. PubMed ID: 36977891
[TBL] [Abstract][Full Text] [Related]
14. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
15. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
Lafage-Proust MH
Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
[TBL] [Abstract][Full Text] [Related]
16. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
17. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
20. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
